The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 09, 2018

Filed:

Aug. 10, 2017
Applicant:

Roche Diagnostics Operations, Inc., Indianapolis, IN (US);

Inventors:

Herbert Andres, Penzberg, DE;

Stefan Weiser, Seehausen, DE;

Johann Karl, Peissenberg, DE;

Ursula Kunert, Munich, DE;

Florian Grupp, Iffeldorf, DE;

Assignee:

Roche Diagnostics Operations, Inc., Indianapolis, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/564 (2006.01); G01N 33/563 (2006.01); G01N 33/58 (2006.01);
U.S. Cl.
CPC ...
G01N 33/564 (2013.01); G01N 33/563 (2013.01); G01N 33/58 (2013.01); G01N 2333/91215 (2013.01); G01N 2800/102 (2013.01);
Abstract

Described is a method aiding in the assessment of rheumatoid arthritis ('RA'). The method is used in assessing RA in vitro. It is practiced by analyzing biochemical markers, including measuring the concentration of anti-CCP and anti-PIK 3CD and correlating the concentrations determined to the absence or presence of RA. Also disclosed is the use of a marker panel including anti-CCP and anti-PIK3CD in the diagnosis of RA and it teaches a kit for performing the method. Also described is the use of a marker panel comprising anti-CCP and anti-PIK3CD to differentiate RA from other autoimmune diseases, preferably osteoarthritis (OA).


Find Patent Forward Citations

Loading…